Logo image of TCRT

ALAUNOS THERAPEUTICS INC (TCRT) Stock Overview

USA - NASDAQ:TCRT - US98973P3091 - Common Stock

3.07 USD
-0.03 (-0.97%)
Last: 10/17/2025, 8:00:01 PM
3.17 USD
+0.1 (+3.26%)
After Hours: 10/17/2025, 8:00:01 PM

TCRT Key Statistics, Chart & Performance

Key Statistics
Market Cap6.72M
Revenue(TTM)6.00K
Net Income(TTM)-3993000
Shares2.19M
Float1.96M
52 Week High6.2
52 Week Low1.31
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-2.46
PEN/A
Fwd PEN/A
Earnings (Next)11-12 2025-11-12
IPO2004-08-20
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


TCRT short term performance overview.The bars show the price performance of TCRT in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 20

TCRT long term performance overview.The bars show the price performance of TCRT in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20 -40 -60 -80

The current stock price of TCRT is 3.07 USD. In the past month the price increased by 26.86%. In the past year, price increased by 35.84%.

ALAUNOS THERAPEUTICS INC / TCRT Daily stock chart

TCRT Latest News, Press Relases and Analysis

TCRT Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 21.68 405.55B
AMGN AMGEN INC 13.7 160.87B
GILD GILEAD SCIENCES INC 15.87 152.38B
VRTX VERTEX PHARMACEUTICALS INC 24.61 106.87B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 63.14B
REGN REGENERON PHARMACEUTICALS 12.67 61.27B
ARGX ARGENX SE - ADR 91.01 51.63B
ONC BEONE MEDICINES LTD-ADR 5.11 34.76B
INSM INSMED INC N/A 35.04B
BNTX BIONTECH SE-ADR N/A 25.28B
NTRA NATERA INC N/A 24.94B
BIIB BIOGEN INC 8.93 20.97B

About TCRT

Company Profile

TCRT logo image Alaunos Therapeutics, Inc. is a biopharmaceutical company and clinical-stage oncology-focused cell therapy company, which engages in the development of adoptive TCR engineered T-cell therapies, or TCR-T, designed to treat multiple solid tumor types in large cancer patient populations with unmet clinical needs. The company is headquartered in Houston, Texas and currently employs 1 full-time employees. The company went IPO on 2004-08-20. The firm focuses on developing small molecules that are expected to be efficacious against obesity and other metabolic disorders. The firm is engaged in developing novel small molecule-based obesity therapeutics. The Company’s operations consist primarily of conducting research and development and raising capital to fund those efforts. The firm has not generated any revenues.

Company Info

ALAUNOS THERAPEUTICS INC

2617 Bissonnet St, Suite 233

Houston TEXAS US

Employees: 1

TCRT Company Website

TCRT Investor Relations

Phone: 13463554099

ALAUNOS THERAPEUTICS INC / TCRT FAQ

What is the stock price of ALAUNOS THERAPEUTICS INC today?

The current stock price of TCRT is 3.07 USD. The price decreased by -0.97% in the last trading session.


What is the ticker symbol for ALAUNOS THERAPEUTICS INC stock?

The exchange symbol of ALAUNOS THERAPEUTICS INC is TCRT and it is listed on the Nasdaq exchange.


On which exchange is TCRT stock listed?

TCRT stock is listed on the Nasdaq exchange.


What is ALAUNOS THERAPEUTICS INC worth?

ALAUNOS THERAPEUTICS INC (TCRT) has a market capitalization of 6.72M USD. This makes TCRT a Nano Cap stock.


How many employees does ALAUNOS THERAPEUTICS INC have?

ALAUNOS THERAPEUTICS INC (TCRT) currently has 1 employees.


What are the support and resistance levels for ALAUNOS THERAPEUTICS INC (TCRT) stock?

ALAUNOS THERAPEUTICS INC (TCRT) has a support level at 3.06 and a resistance level at 3.45. Check the full technical report for a detailed analysis of TCRT support and resistance levels.


Should I buy ALAUNOS THERAPEUTICS INC (TCRT) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ALAUNOS THERAPEUTICS INC (TCRT) stock pay dividends?

TCRT does not pay a dividend.


When does ALAUNOS THERAPEUTICS INC (TCRT) report earnings?

ALAUNOS THERAPEUTICS INC (TCRT) will report earnings on 2025-11-12.


What is the Price/Earnings (PE) ratio of ALAUNOS THERAPEUTICS INC (TCRT)?

ALAUNOS THERAPEUTICS INC (TCRT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.46).


What is the Short Interest ratio of ALAUNOS THERAPEUTICS INC (TCRT) stock?

The outstanding short interest for ALAUNOS THERAPEUTICS INC (TCRT) is 3.67% of its float. Check the ownership tab for more information on the TCRT short interest.


TCRT Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to TCRT. When comparing the yearly performance of all stocks, TCRT is one of the better performing stocks in the market, outperforming 79.01% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

TCRT Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to TCRT. While TCRT has a great health rating, there are worries on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

TCRT Financial Highlights

Over the last trailing twelve months TCRT reported a non-GAAP Earnings per Share(EPS) of -2.46. The EPS decreased by -34.29% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -84.33%
ROE -109.07%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%11.08%
Sales Q2Q%-100%
EPS 1Y (TTM)-34.29%
Revenue 1Y (TTM)0%

TCRT Forecast & Estimates


Analysts
Analysts43.33
Price TargetN/A
EPS Next Y243.33%
Revenue Next YearN/A

TCRT Ownership

Ownership
Inst Owners4.77%
Ins Owners3.57%
Short Float %3.67%
Short Ratio0.45